Catalyst Wire Dossier Catalyst Wire Dossier

UNLOXCYT

COSIBELIMAB · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for UNLOXCYT, covering 2024-12-13 to 2025-11-21. Get the full timeline:

Most recent: FDA Approved: UNLOXCYT — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

See pricing